Deletion of the carboxy-terminus of herpes simplex virus type 1 (HSV- 1) glycoprotein B does not affect oligomerization, heparin-binding activity, or its ability to protect against HSV challenge

Archives of Virology

Volumn 141, Issue 6, 1996, Pages 1153-1165

  Lin, X H ^a   Ali, M A ^a   Openshaw, H ^a   Cantin, E M ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; HERPES; HUMAN HERPESVIRUS 1; VACCINIA; VACCINIA VIRUS;

EID: 0029742945     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01718618     Document Type: Article

References (33)

1. Ali MA (1990) Oligomerization of herpes simplex virus glycoprotein B occurs in the endoplasmic reticulum and a 102 amino acids cytosolic domain is dispensable for dimer assembly. Virology 178: 588-592
2. Ali MA, Butcher M, Ghosh HP (1987) Expression and nuclear envelope localization of biologically active fusion glycoprotein gB of herpes simplex virus in mammalian cells using cloned DNA. Proc Natl Acad Sci USA 84: 5675-5679
3. Biochemica Information (1987) Boehringer Mannheim, 1st ed, pp 140-141
4. Burke RL (1992) Contemporary approaches to vaccination against herpes simplex virus. Curr Top Microbiol Immunol 179: 137-158
5. Bzik DJ, Debroy C, Fox BA, Pederson N, Person S (1986) The nucleotide sequence of the gB glycoprotein of HSV-2 and comparison with corresponding gene of HSV-1. Virology 155: 322-333
6. Bzik DJ, Fox BA, DeLuca N, Person S (1984) Nucleotide sequence specifying the glycoprotein gene gB of herpes simplex virus type 1. Virology 133: 301-314
7. Cai W, Person S, Warner SC, Zhov J, DeLuca NA (1987) Linker-insertion nonsense and restriction-site delation mutations of the gB glycoprotein gene of herpes simplex virus type 1. J Virol 61: 714-721
8. Cantin EM, Eberle R, Baldick B, Moss B, Willey DE, Notkins AL, Openshaw H (1987) Expression of herpes simplex virus glycoprotein B by recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proc Natl Acad Sci USA 84: 5908-5912
9. Cleasson-Welsh L, Spear PG (1986) Oligomerization of herpes simplex virus glycoprotein BJ Virol 60: 803-806
10. Dix RD, Mills J (1985) Acute and latent herpes simplex virus neurological disease in mice immunized with purified virus-specific glycoproteins gB or gD. J Med Virol 17: 9-18
11. Ghiasi H, Kaiwar R, Nesburn AB, Slanina S, Wechsler SL (1994) Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J Virol 68: 2118-2126
12. Hanke T, Graham FL, Rosenthal KL, Johnson DC (1991) Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides. J Virol 65: 1177-1186
13. Herold BC, WuDunn D, Soltys N, Spear PG (1991) Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol 65: 1090-1098
14. Highlander SL, Cai W, Person S, Levine M, Glorioso JC (1988) Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration. J Virol 62: 1881-1888
15. Highlander SL, Goins W, Person S, Holland TC, Levine M, Glorioso JC (1991) Oligomer formation of gB glycoprotein of herpes simplex virus type 1. J Virol 65: 4275-4283
16. Hill A, Jugovic P, York I, Russ G, Bennik J, Yewdell J, Ploege H, Johson D (1995) Herpes simplex virus turns off the TAP to evade host immunity. Nature 375: 411-415
17. Little SP, Jofre JT, Courtney RJ, Schaffer PA (1981) A virion-associated glycoprotein essential for infectivity of herpes simplex virus type 1. Virology 115: 149-160
18. Manservigi R, Grossi MP, Gualandri R, Balboni PG, Marchini A, Rotola A, Rimessi P, Di Luca D, Barbanti-Brodano G (1990) Protection from herpes simplex type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed human cells with a BK virus episomal vector. J Virol 64: 431-436
19. Manservigi R, Spear PG, Buchan A (1977) Cell fusion induced by herpes simplex virus is promoted and suppressed by different viral glycoproteins. Proc Natl Acad Sci USA 74: 3913-3917
20. McDermott MR, Graham FL, Hanke T, Johnson DC (1989) Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B. Virology 169: 244-247
21. McLaughlin-Taylor E, Willey DE, Cantin EM, Eberle R, Moss B, Openshaw H (1988) A vaccinia recombinant virus expressing herpes simplex virus type 1 glycoprotein B induces cytotoxic T lymphocytes in mice. J Gen Virol 69: 1731-1734
22. Navarro D, Paz P, Pereira L (1992) Domains of herpes simplex virus type 1 glycoprotein that function in virus penetration, cell-to-cell spread and cell fusion. Virology 186: 99-112
23. Pachl C, Burke RL, Stuve LL, Sanchez-Pescador L, van Nest G, Masiarz F, Dina D (1987) Expression of cell associated and secreted forms of herpes simplex virus type 1 glycoprotein B in mammalian cells. J Virol 61: 315-325
24. Pellett PE, Kousoulas KG, Pereira L, Roizman B (1985) Anatomy of herpes simplex virus 1 strain F glycoprotein B gene: primary sequence and predicted protein structure of the wild type and of monoclonal antibody resistant-mutants. J Virol 53: 243-253
25. Qadri I, Gimeno C, Nevarro D, Pereira L (1991) Mutations in discontinuos domains of herpes simplex virus 1 glycoprotein B affect the antigenic properties, dimerization, and cell-surface transport of the molecule. Virology 180: 135-152
26. Rasile L, Ghosh K, Raviprakash K, Ghosh HP (1993) Effect of deletions in the carboxy-terminal hydrophobic region of herpes simplex virus glycoprotein B on intracellular transport and membrane anchoring. J Virol 67: 4856-4866
27. Sarmiento M, Haffey M, Spear PG (1979) Membrane proteins specified by herpes simplex viruses III. Role of glycoprotein VP7(B2) in virion infectivity. J Virol 29: 1149-1158
28. Schmid DS, Rouse BT (1992) The role of T cell immunity in control of herpes simplex virus. Curr Top Microbiol Immunol 179: 57-74
29. Showalter D, Zweig M, Hampar B (1981) Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate- darly protein ICP 4. Infect Immun 34: 684-692
30. Spear PG (1993) Membrane fusion induced by herpes simplex virus. In: Bentz J (ed) Viral fusion mechanisms. CRC Press, Boca Raton, pp 201-232
31. Spear PG (1993a) Entry of alphaherpesviruses into cells. Semin Virol 4: 167-180
32. Willey DE, Cantin EM, Hill HR, Moss B, Notkins AL, Openshaw H (1988) Herpes simplex virus type 1 vaccinia recombinant expressing glycoprotein B: protection from acute and latent infection. J Infect Dis 158: 1382-1385
33. Witmer LA, Rosenthal KL, Graham FL, Freidman HM, Yee A, Johnson DC (1990) Cytotoxic T lymphocytes specific for herpes simplex virus (HSV) studied using adenovirus vectors expressing HSV glycoproteins J Gen Virol 71: 387-396